Atlas Trials

Clinical Study of MAK Immune Cells in the Treatment of PHC

Clinical trial NCT05242757 · UNKNOWN

Trial details

NCT number
NCT05242757
Sponsor
Zhongnan Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Primary Hepatocellular Carcinoma
Start date
2021-01-01
Primary completion
2022-03-31
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.